NOX enzymes in the central nervous system: From signaling to disease

Antioxidants and Redox Signaling

Volumn 11, Issue 10, 2009, Pages 2481-2504

  Sorce, Silvia ^a   Krause, Karl Heinz ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; 4 AMINOBUTYRIC ACID RECEPTOR; AMYLOID BETA PROTEIN; APOCYNIN; ATORVASTATIN; DIPHENYLIODONIUM SALT; GLUTAMATE RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; PROTEIN P22; RAC1 PROTEIN; RAC2 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; ASTROCYTE; BRAIN; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; INFLAMMATION; MENTAL DISEASE; MICROGLIA; MITOCHONDRION; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STROKE; SUBSTANTIA NIGRA;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE; NADPH OXIDASE; NERVOUS SYSTEM DISEASES; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 67651184281     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2578     Document Type: Review

References (280)

1. ALS TDI Animal Studies [Online]. ALS Therapy Development Institute. http://www.als.net/research/studies/tdfAnimalStudyDetail.asp?studyType = internal&studyID = 662. 2009, Jan. 9.
2. Abramov AY, Canevari L, and Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24: 565-575, 2004. (Pubitemid 38112390)
3. Abramov AY, Canevari L, and Duchen MR. Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 1742: 81-87, 2004. (Pubitemid 39601768)
4. Abramov AY and Duchen MR. The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides. Phil Trans R Soc hand B Biol Sci 360: 2309-2314, 2005.
5. Abramov AY, Jacobson J, Wientjes F, Hothersall J, Canevari L, and Duchen MR. Expression and modulation of an NADPH oxidase in mammalian astrocytes. J. Neurosci 25: 9176-9184, 2005. (Pubitemid 41500826)
6. Abramov AY, Scorziello A, and Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci 17: 1129-1138, 2007. (Pubitemid 46203321)
7. Anantharam V, Kaul S, Song C, Kanthasamy A, and Kanthasamy AG. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology 28: 988-997, 2007. (Pubitemid 47519806)
8. Atmaca M, Kuloglu M, Tezcan E, and Ustundag B. Antioxidant enzyme and malondialdehyde levels in patients with social phobia. Psychiatry Res 159: 95-100, 2008.
9. Aygul R, Demircan B, Erdem F, Ulvi H, Yildirim A, and Demirbas F. Plasma values of oxidants and antioxidants in acute brain hemorrhage: role of free radicals in the development of brain injury. Biol Trace Elem Res 108:43-52, 2005. (Pubitemid 41752498)
10. Bamberger ME, Harris ME, McDonald DR, Husemann J, and Landreth GE. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci. 23: 2665-2674, 2003. (Pubitemid 36418601)
11. Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, and Krause KH. NOX3: A superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 279: 46065-46072, 2004. (Pubitemid 39491600)
12. Banfi B, Schrenzel J, Nusse O, Lew DP, Ligeti E, Krause KH, and Demaurex N. A novel H(+) conductance in eosinophils: unique characteristics and absence in chronic granulomatous disease. J Exp Med 190: 183-194, 1999. (Pubitemid 29354912)
13. Barger SW, Goodwin ME, Porter MM, and Beggs ML. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem 101: 1205-1213, 2007.
14. Bayer TA, Buslei R, Havas L, and Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett 271: 126-128, 1999. (Pubitemid 29400683)
15. Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, and Olsson T. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J Immunol 176: 6055-6064, 2006.
16. Bedard K and Krause KH. The NOX family of ROSgenerating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007. (Pubitemid 46209993)
17. Beers DR, Henkel JS, Zhao W, Wang J, and Appel SH. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci USA 105:15558-15563,2008.
18. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, and Dugan LL. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318: 1645-1647, 2007. (Pubitemid 350233667)
19. Behrens MM, Ali SS, and Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 28: 13957-13966, 2008.
20. Bianca VD, Dusi S, Bianchini E, Dal Pra I, and Rossi F. Betaamyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils: a possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274: 15493-15499, 1999. (Pubitemid 129518900)
21. Block ML. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 9(suppl 2): S8, 2008.
22. Block ML, Li G, Qin L, Wu X, Pei Z, Wang T, Wilson B, Yang J, and Hong JS. Potent regulation of microgliaderived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J 20: 251-258, 2006. (Pubitemid 44933172)
23. Block ML, Wu X, Pei Z, Li G, Wang T, Qin L, Wilson B, Yang J, Hong JS, and Veronesi B. Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J 18: 1618-1620, 2004. (Pubitemid 39561652)
24. Block ML, Zecca L, and Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69, 2007. (Pubitemid 46011999)
25. Boillee S, Vande Velde C, and Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59, 2006. (Pubitemid 44466358)
26. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, and Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392, 2006. (Pubitemid 43839552)
27. Bonneh-Barkay D, Reaney SH, Langsten WJ, and Di Monte DA. Redox cycling of the herbicide paraquat in microglial cultures. Brain Res Mol Brain Res 134: 52-56, 2005. (Pubitemid 40403639)
28. Bromet EJ and Fennig S. Epidemiology and natural history of schizophrenia. Biol Psychiatry 46: 871-881, 1999.
29. Brown GC. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35: 1119-1121, 2007.
30. Calabrese V, Bella R, Testa D, Spadaro F, Scrofani A, Rizza V, and Pennisi G. Increased cerebrospinal fluid and plasma levels of ultraweak chemiluminescence are associated with changes in the thiol pool and lipid-soluble fluorescence in multiple sclerosis: the pathogenic role of oxidative stress. Drugs Exp Clin Res 24: 125-131, 1998. (Pubitemid 28499567)
31. Campese VM, Sindhu RK, Ye S, Bai Y, Vaziri ND, and Jabbari B. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Res 1134: 27-32, 2007. (Pubitemid 46135539)
32. Cao X, Dai X, Parker LM, and Kreulen DL. Differential regulation of NADPH oxidase in sympathetic and sensory ganglia in deoxycorticosterone acetate salt hypertension. Hypertension 50: 663-671, 2007. (Pubitemid 47442729)
33. Casarejos MJ, Menendez J, Solano RM, Rodriguez-Navarro JA, Garcia de Yebenes J, and Mena MA. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem 97: 934-946, 2006.
34. Chan SH, Hsu KS, Huang CC, Wang LL, Ou CC, and Chan JY. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 97: 772-780, 2005.
35. Chan SH, Wang LL, Tseng HL, and Chan JY. Upregulation of ATI receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERKl/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. J Hypertens 25: 1845-1861, 2007.
36. Chen H, Wang S, Ding JH, and Hu G. Edaravone protects against MPP +-induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway. J Neurochem 106: 2345-2352, 2008.
37. Chen K, Kirber MT, Xiao H, Yang Y, and Keaney JF Jr. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 181: 1129-1139, 2008. (Pubitemid 351915488)
38. Cheng G, Cao Z, Xu X, Meir EG, and Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001. (Pubitemid 32488913)
39. Cheret C, Gervais A, Lelli A, Colin C, Amar L, Ravassard P, Mallet J, Cumano A, Krause KH, and Mallat M. Neurotoxic activation of microglia is promoted by a NOXl-dependent NADPH oxidase. J Neurosci 28: 12039-12051, 2008.
40. Choi JW, Shin CY, Yoo BK, Choi MS, Lee WJ, Han BH, Kim WK, Kim HC, and Ko KH. Glucose deprivation increases hydrogen peroxide level in immunostimulated rat primary astrocytes. J Neurosci Res 75: 722-731, 2004.
41. Choi SH, Lee DY, Chung ES, Hong YB, Kim SU, and Jin BK. Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem 95: 1755-1765, 2005.
42. Choi SH, Lee DY, Kim SU, and Jin BK. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 25: 4082-11090, 2005.
43. Chrissobolis S and Faraci FM. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med 14: 495-502, 2008.
44. Chu J, Tong M, and de la Monte SM. Chronic ethanol exposure causes mitochondrial dysfunction and oxidative stress in immature central nervous system neurons. Acta Neuropathol 113: 659-673, 2007. (Pubitemid 46863902)
45. Cohen AC, Tong M, Wands JR, and de la Monte SM. Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model. Alcohol Clin Exp Res 31: 1558-1573, 2007. (Pubitemid 47319658)
46. Coyoy A, Valencia A, Guemez-Gamboa A, and Moran J. Role of NADPH oxidase in the apoptotic death of cultured cerebellar granule neurons. Free Radic Biol Med 45: 1056-1064, 2008. Epub 2008 Jul 2.
47. Cross AR and Segal AW. The NADPH oxidase of professional phagocytes: prototype of the NOX electron transport chain systems. Biochim Biophys Acta 1657: 1-22, 2004.
48. Dai X, Cao X, and Kreulen DL. Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase. Am J Physiol Heart Circ Physiol 290: H1019-H1026, 2006.
49. de la Monte SM and Wands JR. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J; Alzheimers Dis 9: 167-181, 2006.
50. DeCoursey TE. Voltage-gated proton channels. Cell Mol Life Sci 65: 2554-2573, 2008.
51. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 6: 149-161, 2007.
52. Dingledine R, Borges K, Bowie D, and Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 51: 7-61, 1999.
53. Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, and Cuenod M. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12: 3721-3728, 2000. (Pubitemid 30796074)
54. Dohi K, Mochizuki Y, Satoh K, Jimbo H, Hayashi M, Toyoda I, Ikeda Y, Abe T, and Aruga T. Transient elevation of serum bilirubin (a heme oxygenase-1 metabolite) level in hemorrhagic stroke: bilirubin is a marker of oxidant stress. Acta Neurochir Suppl 86: 247-249, 2003.
55. Doverhag C, Keller M, Karlsson A, Hedtjarn M, Nilsson U, Kapeller E, Sarkozy G, Klimaschewski L, Humpel C, Hagberg H, Simbruner G, Gressens P, and Savman K. Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol Dis 31: 133-144, 2008. (Pubitemid 351833142)
56. Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 7: 1223-1233, 2005. (Pubitemid 41232519)
57. Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Brain Res Rev 20: 250-267, 1995.
58. Emerit J, Edeas M, and Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58: 39-46, 2004.
59. Farfara D, Lifshitz V, and Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J Cell Mol Med 12: 762-780, 2008. (Pubitemid 351718063)
60. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH Jr, and Beal MF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69: 2064-2074, 1997. (Pubitemid 27452754)
61. Ferro JM, Canhao P, and Peralta R. Update on subarachnoid haemorrhage. J Neurol 255: 465-1179, 2008.
62. Gaetani P, Pasqualin A, Rodriguez y Baena R, Borasio E, and Marzatico F. Oxidative stress in the human brain after subarachnoid hemorrhage. J Neurosurg 89: 748-754, 1998.
63. Gao HM, Hong JS, Zhang W, and Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 22: 782-790, 2002. (Pubitemid 34141759)
64. Gao HM, Hong JS, Zhang W, and Liu B. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci 23: 1228-1236, 2003. (Pubitemid 36258901)
65. Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, and Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 81: 1285-1297, 2002. (Pubitemid 34809262)
66. Gao HM, Liu B, and Hong JS. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 23: 6181-6187, 2003. (Pubitemid 36875618)
67. Gao HM, Liu B, Zhang W, and Hong JS. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J 17: 1954-1956, 2003.
68. Gao HM, Liu B, Zhang W, and Hong JS. Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. FASEB J 17: 1957-1959, 2003.
69. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, and Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 95: 937-944, 2004. (Pubitemid 39435009)
70. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, and Zucker IH. Sympathoexcitation by central ANG II: roles for ATI receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 288: H2271-H2279, 2005. (Pubitemid 40604115)
71. Gao X, Hu X, Qian L, Yang S, Zhang W, Zhang D, Wu X, Fraser A, Wilson B, Flood PM, Block M, and Hong JS. Formyl-methionyl-leucyl-phenylalanine-induced dopaminergic neurotoxicity via microglial activation: a mediator between peripheral infection and neurodegeneration? Environ Health Perspect 116: 593-1398, 2008. (Pubitemid 351864273)
72. Garrido AM and Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302: 148-158, 2008. Epub 2008 Nov 18.
73. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, and Krause KH. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 580: 497-504, 2006. (Pubitemid 43089678)
74. Gavazzi G, Deffert C, Trocme C, Schappi M, Herrmann FR, and Krause KH. NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 50: 189-196, 2007. (Pubitemid 46992019)
75. Genius J, Grau AJ, and Lichy C. The C242T polymorphism of the NAD(P)H oxidase p22phox subunit is associated with an enhanced risk for cerebrovascular disease at a young age. Cerebrovasc Dis 26: 430-433, 2008.
76. Glass MJ, Chan J, Frys KA, Oselkin M, Tarsitano MJ, Iadecola C, and Pickel VM. Changes in the subcellular distribution of NADPH oxidase subunit p47phox in dendrites of rat dorsomedial nucleus tractus solitarius neurons in response to chronic administration of hypertensive agents. Exp Neurol 205: 383-395, 2007. (Pubitemid 46755760)
77. Glass MJ, Huang J, Oselkin M, Tarsitano MJ, Wang G, Iadecola C, and Pickel VM. Subcellular localization of nicotinamide adenine dinucleotide phosphate oxidase subunits in neurons and astroglia of the rat medial nucleus tractus solitarius: relationship with tyrosine hydroxylase immunoreactive neurons. Neuroscience 143: 547-564, 2006. (Pubitemid 44716596)
78. Gong YH, Parsadanian AS, Andreeva A, Snider WD, and Elliott JL. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 20: 660-665, 2000. (Pubitemid 30225568)
79. Gorg B, Qvartskhava N, Keitel V, Bidmon HJ, Selbach O, Schliess F, and Haussinger D. Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo. Hepatology 48: 567-579, 2008.
80. Green SP, Cairns B, Rae J, Errett-Baroncini C, Hongo JA, Erickson RW, and Curnutte JT. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J Cereb Blood Flow Metab 21: 374-384, 2001. (Pubitemid 32298884)
81. Greve B, Hoffmann P, Vonthein R, Kun J, Lell B, Mycko MP, Selmaj KW, Berger K, Weissert R, and Kremsner PG. NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. Malar J 7: 251, 2008.
82. Griendling KK, Lassegue B, and Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 36: 281-306, 1996. (Pubitemid 26169900)
83. Griendling KK and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91: 21-27, 2000. (Pubitemid 30674466)
84. Gross C and Hen R. The developmental origins of anxiety. Nat Rev Neurosci 5: 545-552, 2004.
85. Guggilam A, Haque M, Kerut EK, McIlwain E, Lucchesi P, Seghal I, and Francis J. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am J Physiol Heart Circ Physiol 293: H599-H609, 2007.
86. Guidarelli A, Palomba L, Fiorani M, and Cantoni O. Susceptibility of rat astrocytes to DNA strand scission induced by activation of NADPH oxidase and collateral resistance to the effects of peroxynitrite. Free Radic Biol Med 45: 521-529, 2008.
87. Gurney ME. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci 152(suppl 1): S67-S73, 1997.
88. Haataja L, Groffen J, and Heisterkamp N. Characterization of RAC3, a novel member of the Rho family. J Biol Chem 272: 20384-20388, 1997. (Pubitemid 27355588)
89. Haorah J, Ramirez SH, Floreani N, Gorantla S, Morsey B, and Persidsky Y. Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med 45: 1542-1550, 2008.
90. Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schoneich C, and Engelhardt JF. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118: 659-670, 2008. (Pubitemid 351206555)
91. Harrigan TJ, Abdullaev IF, Jourd'heuil D, and Mongin AA. Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases. J Neurochem 106: 2449-2462, 2008. Epub 2008 Jul 9.
92. Hashimoto Y, Niikura T, Ito Y, Kita Y, Terashita K, and Nishimoto I. Neurotoxic mechanisms by Alzheimer's diseaselinked N141I mutant presenilin 2. J Pharmacol Exp Ther 300: 736-745, 2002. (Pubitemid 34164974)
93. Hashimoto Y, Tsukamoto E, Niikura T, Yamagishi Y, Ishizaka M, Aiso S, Takashima A, and Nishimoto I. Aminoand carboxyl-terminal mutants of presenilin 1 cause neuronal cell death through distinct toxic mechanisms: study of 27 different presenilin 1 mutants. J Neurosci Res 75: 417-428, 2004. (Pubitemid 38173478)
94. Hauser SL and Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52: 61-76, 2006. (Pubitemid 44466355)
95. Helmcke I, Heumuller S, Tikkanen R, Schroder K, and Brandes RP. Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid Redox Signal 11: 1279-1287, 2009.
96. Henchcliffe C and Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4: 600-609, 2008.
97. Hensley K, Mhatre M, Mou S, Pye QN, Stewart C, West M, and Williamson KS. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signal 8: 2075-2087, 2006. (Pubitemid 46489632)
98. Hicks JB, Lai Y, Sheng W, Yang X, Zhu D, Sun GY, and Lee JC. Amyloid-beta peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A2. Biochim Biophys Acta 1778: 2512-2519, 2008.
99. Hidalgo C, Carrasco MA, Muñoz P, and Nunez MT. A role for reactive oxygen/nitrogen species and iron on neuronal synaptic plasticity. Antioxid Redox Signal 9: 245-255, 2007. (Pubitemid 46105423)
100. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004. (Pubitemid 38451603)
101. Hong H, Zeng JS, Kreulen DL, Kaufman DI, and Chen AF. Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am ] Physiol Heart Circ Physiol 291: H2210-H2215, 2006. (Pubitemid 44776647)
102. Hordijk PL. Regulation of NADPH oxidases: the role of Rac proteins. Circ Res 98: 453-462, 2006.
103. Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM, Ellison JA, Schadt EE, Verma IM, Lockhart DJ, and Barlow C. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438: 662-666, 2005. (Pubitemid 41740575)
104. Hu X, Zhang D, Pang H, Caudle WM, Li Y, Gao H, Liu Y, Qian L, Wilson B, Di Monte DA, Ali SF, Zhang J, Block ML, and Hong JS. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J Immunol 181: 7194-7204, 2008.
105. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, and Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 101: 12646-12651, 2004. (Pubitemid 39122077)
106. Ibi M, Katsuyama M, Fan C, Iwata K, Nishinaka T, Yokoyama T, and Yabe-Nishimura C. NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth. Free Radic Biol Med 40:1785-1795, 2006.
107. Ibi M, Matsuno K, Shiba D, Katsuyama M, Iwata K, Kakehi T, Nakagawa T, Sango K, Shirai Y, Yokoyama T, Kaneko S, Saito N, and Yabe-Nishimura C. Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. J Neurosci 28: 9486-9494, 2008.
108. Inf anger DW, Sharma RV, and Davisson RL. NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal 8:1583-1596, 2006.
109. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, Tanahashi N, and Fukuuchi Y. C242T polymorphism of NADPH oxidase p22phox gene and ischemic cerebrovascular disease in the Japanese population. Stroke. 31: 936-939, 2000. (Pubitemid 30198442)
110. Jana A and Pahan K. Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase. J Neurosci 24: 9531-9540, 2004. (Pubitemid 39441507)
111. 2 derived from NADPH oxidase: a cell culture study. J Neuroinflamm 3: 24, 2006.
112. Jenner P, Dexter DT, Sian J, Schapira AH, and Marsden CD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease: the Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 32(suppl): S82-S87, 1992.
113. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, and Brandes RP. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38: 3000-3006, 2007. (Pubitemid 350035696)
114. Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, and Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis 15: 473-1193, 2008.
115. Kantarci OH. Genetics and natural history of multiple sclerosis. Semin Neurol 28: 7-16, 2008. (Pubitemid 351273080)
116. Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, and Swanson RA. Zinc triggers microglial activation. J Neurosci 28: 5827-5835, 2008.
117. Kaynar MY, Tanriverdi T, Kemerdere R, Atukeren P, and Gumustas K. Cerebrospinal fluid superoxide dismutase and serum malondialdehyde levels in patients with aneurysmal subarachnoid hemorrhage: preliminary results. Neurol Res 27: 562-567, 2005. (Pubitemid 41040847)
118. Kim-Mitsuyama S, Yamamoto E, Tanaka T, Zhan Y, Izumi Y, Izumiya Y, Ioroi T, Wanibuchi H, and Iwao H. Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats. Stroke 36:1083-1088, 2005. (Pubitemid 40629306)
119. Kim DE, Suh YS, Lee MS, Kim KY, Lee JH, Lee HS, Hong KW, and Kim CD. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 33: 2687-2691, 2002.
120. Kim MJ, Shin KS, Chung YB, Jung KW, Cha CI, and Shin DH. Immunohistochemical study of p47PHOX and gp91phox distributions in rat brain. Brain Res 1040: 178-186, 2005.
121. Kim S, Hwang J, Lee WH, Hwang DY, and Suk K. Role of protein kinase Cdelta in paraquat-induced glial cell death. J Neurosci Res 86: 2062-2070, 2008.
122. Kim SH, Won SJ, Sohn S, Kwon HJ, Lee JY, Park JH, and Gwag BJ. Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase. J Cell Biol 159:821-831, 2002. (Pubitemid 36008364)
123. Kim SY, Moon JH, Lee HG, Kim SU, and Lee YB. ATP released from beta-amyloid-stimulated microglia induces reactive oxygen species production in an autocrine fashion. Exp Mol Med 39: 820-827, 2007.
124. Kim YS, Choi DH, Block ML, Lorenzl S, Yang L, Kim YJ, Sugama S, Cho BP, Hwang O, Browne SE, Kim SY, Hong JS, Beal MF, and Joh TH. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J 21: 179-187, 2007. (Pubitemid 46052555)
125. Kishida KT, Hoeffer CA, Hu D, Pao M, Holland SM, and Klann E. Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol Cell Biol 26: 5908-5920, 2006. (Pubitemid 44134344)
126. Kishida KT and Klann E. Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid Redox Signal 9: 233-244, 2007. (Pubitemid 46105422)
127. Kishida KT, Pao M, Holland SM, and Klann E. NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J Neurochem 94:299-306, 2005. (Pubitemid 40995246)
128. Kiss PJ, Knisz J, Zhang Y, Baltrusaitis J, Sigmund CD, Thalmann R, Smith RJ, Verpy E, and Banfi B. Inactivation of NADPH oxidase organizer 1 results in severe imbalance. Curr Biol 16: 208-213, 2006. (Pubitemid 43117437)
129. Kranc KR, Pyne GJ, Tao L, Claridge TD, Harris DA, Cadoux-Hudson TA, Turnbull JJ, Schofield CJ, and Clark JF. Oxidative degradation of bilirubin produces vasoactive compounds. Eur J Biochem 267: 7094-8101, 2000. (Pubitemid 32009450)
130. Krause KH. Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp Gerontol 42: 256-262, 2007.
131. Krex D, Ziegler A, Konig IR, Schackert HK, and Schackert G. Polymorphisms of the NADPH oxidase p22phox gene in a Caucasian population with intracranial aneurysms. Cerebrovasc Dis 16: 363-368, 2003. (Pubitemid 37140425)
132. Kuloglu M, Atmaca M, Tezcan E, Ustundag B, and Bulut S. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 46: 186-189, 2002. (Pubitemid 36173366)
133. Kuroda J, Kitazono T, Ago T, Ninomiya T, Ooboshi H, Kamouchi M, Kumai Y, Hagiwara N, Yoshimura S, Tamaki K, Kusuda K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Asano K, Tanizaki Y, Kiyohara Y, Ibayashi S, and Iida M. NAD(P)H oxidase p22phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama study. Eur J Neurol 14: 1091-1097, 2007. (Pubitemid 47459733)
134. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
135. Lambeth JD, Krause KH, and Clark RA. NOX enzymes as novel targets for drug development. Semin Immunopathol 30: 339-363, 2008.
136. Lewis DA and Lieberman JA. Catching up on schizophrenia: natural history and neurobiology. Neuron 28: 325-334, 2000.
137. Li B, Guo YS, Sun MM, Dong H, Wu SY, Wu DX, and Li CY. The NADPH oxidase is involved in lipopolysaccharidemediated motor neuron injury. Brain Res 1226: 199-208, 2008.
138. Li G, Cui G, Tzeng NS, Wei SJ, Wang T, Block ML, and Hong JS. Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage. FASEB J 19: 489-1196, 2005. (Pubitemid 40471239)
139. Li J, Baud O, Vartanian T, Volpe JJ, and Rosenberg PA. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A 102: 9936-9941, 2005. (Pubitemid 40993671)
140. Li J, Ramenaden ER, Peng J, Koito H, Volpe JJ, and Rosenberg PA. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci 28: 5321-5330, 2008.
141. Li Y, Hu X, Liu Y, Bao Y, and An L. Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. Neuropharmacology 56: 580-589, 2009. Epub 2008 Nov 21.
142. Liang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ, and Andreasson K. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol 64: 304-314, 2008.
143. Lino MM, Schneider C, and Caroni P. Accumulation of SODl mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22: 4825-11832, 2002. (Pubitemid 37465597)
144. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568, 1999. (Pubitemid 29473320)
145. Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, and Bankston LA. Cysteine regulation of protein function: as exemplified by NMDA-receptor modulation. Trends Neurosci 25: 474-480, 2002. (Pubitemid 35223002)
146. Liu D, Gao L, Roy SK, Cornish KG, and Zucker IH. Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circ Res 103: 186-193, 2008.
147. Liu Q, Kang JH, and Zheng RL. NADPH oxidase produces reactive oxygen species and maintains survival of rat astrocytes. Cell Biochem Funct 23: 93-100, 2005. (Pubitemid 40363680)
148. Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, and Zhang JH. Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can J Neurol Sci 34: 356-361, 2007. (Pubitemid 47359843)
149. Liu W, Sood R, Chen Q, Sakoglu U, Hendren J, Cetin O, Miyake M, and Liu KJ. Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. J Neurochem 107: 1196-1205, 2008.
150. Liu Y, Hao W, Letiembre M, Walter S, Kulanga M, Neumann H, and Fassbender K. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47phox-mediated generation of reactive oxygen species. J Neurosci 26: 12904-12913, 2006. (Pubitemid 44954610)
151. Lucas M, Sanchez-Solino O, Solano F, and Izquierdo G. Interferon beta-lb inhibits reactive oxygen species production in peripheral blood monocytes of patients with relapsing-remitting multiple sclerosis. Neurochem Int 33: 101-102, 1998. (Pubitemid 28410133)
152. Lv X, Su L, Yin D, Sun C, Zhao J, Zhang S, and Miao J. Knockdown of integrin beta4 in primary cultured mouse neurons blocks survival and induces apoptosis by elevating NADPH oxidase activity and reactive oxygen species level. Int J Biochem Cell Biol 40: 689-699, 2008. (Pubitemid 351288588)
153. Ma L and Zhou J. Dopamine promotes the survival of embryonic striatal cells: involvement of superoxide and endogenous NADPH oxidase. Neurochem Res 31:463-471, 2006. (Pubitemid 43873740)
154. Maccioni RB, Munoz JP, and Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32: 367-381, 2001. (Pubitemid 32918139)
155. Mallolas J, Hurtado O, Castellanos M, Blanco M, Sobrino T, Serena J, Vivancos J, Castillo J, Lizasoain I, Moro MA, and Davalos A. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med 203:711-717, 2006.
156. Mander PK, Jekabsone A, and Brown GC. Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase. J Immunol 176:1046-1052, 2006. (Pubitemid 43099705)
157. Mao H, Fang X, Floyd KM, Polcz JE, Zhang P, and Liu B. Induction of microglial reactive oxygen species production by the organochlorinated pesticide dieldrin. Brain Res 1186: 267-274, 2007.
158. Mao H and Liu B. Synergistic microglial reactive oxygen species generation induced by pesticides lindane and dieldrin. Neuroreport 19:1317-1320, 2008.
159. Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, and Gage FH. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3:649-657, 2008.
160. Marden JJ, Harraz MM, Williams AJ, Nelson K, Luo M, Paulson H, and Engelhardt JF. Redox modifier genes in amyotrophic lateral sclerosis in mice. J Clin Invest 117: 2913-2919, 2007. (Pubitemid 47529621)
161. Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, and Mallat M. Microglia promote the death of developing Purkinje cells. Neuron 41:535-547, 2004. (Pubitemid 38253066)
162. Masood A, Nadeem A, Mustafa SJ, and O'Donnell JM. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther 326: 369-379, 2008.
163. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Noxl-deficient mice. Circulation 112:2677-2685, 2005. (Pubitemid 41532605)
164. McCann SK, Dusting GJ, and Roulston CL. Early increase of Nox4 NADPH oxidase and superoxide generation following endothelin-1-induced stroke in conscious rats. J Neurosci Res 86:2524-2534, 2008.
165. McGeer PL, Itagaki S, Boyes BE, and McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291, 1988. (Pubitemid 18218619)
166. Mehta SL, Manhas N, and Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54:34-66, 2007. (Pubitemid 46498164)
167. Miller AA, Drummond GR, and Sobey CG. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther 111:928-948, 2006.
168. Miller AA, Dusting GJ, Roulston CL, and Sobey CG. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke. Brain Res 1111:111-116, 2006.
169. Miller RL, Sun GY, and Sun AY. Cytotoxicity of paraquat in microglial cells: involvement of PKCdelta- and ERK1/ 2-dependent NADPH oxidase. Brain Res 1167:129-139, 2007.
170. Milton RH, Abeti R, Averaimo S, DeBiasi S, Vitellaro L, Jiang L, Curmi PM, Breit SN, Duchen MR, and Mazzanti M. CLIC1 function is required for beta-amyloid-induced generation of reactive oxygen species by microglia. J Neurosci 28:11488-11499, 2008.
171. Min KJ, Pyo HK, Yang MS, Ji KA, Jou I, and Joe EH. Gangliosides activate microglia via protein kinase C and NADPH oxidase. Glia 48:197-206, 2004. (Pubitemid 39545935)
172. Munnamalai V and Suter DM. Reactive oxygen species regulate F-actin dynamics in neuronal growth cones and neurite outgrowth. J Neurochem 108:644-661, 2009.
173. Musset B, Cherny W, Morgan D, and Decoursey TE. The intimate and mysterious relationship between proton channels and NADPH oxidase. FEBS Lett 583:7-12, 2009.
174. Nakano Y, Longo-Guess CM, Bergstrom DE, Nauseef WM, Jones SM, and Banfi B. Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice. J Clin Invest 118:1176-1185, 2008.
175. Nauseef WM. Nox enzymes in immune cells. Semin Immunopathol 30:195-208, 2008.
176. Ng F, Berk M, Dean O, and Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11:851-876, 2008.
177. Noh KM and Koh JY. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20:RC111, 2000.
178. Oh YT, Lee JY, Yoon H, Lee EH, Baik HH, Kim SS, Ha J, Yoon KS, Choe W, and Kang I. Lipopolysaccharide induces hypoxia-inducible factor-1 alpha mRNA expression and activation via NADPH oxidase and Sp1-dependent pathway in BV2 murine microglial cells. Neurosci Lett 431:155-160, 2008.
179. Oksenberg JR, Baranzini SE, Sawcer S, and Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 9:516-526, 2008. (Pubitemid 351861542)
180. Ostrowski RP, Colohan AR, and Zhang JH. Neuroprotective effect of hyperbaric oxygen in a rat model of subarachnoid hemorrhage. Acta Neurochir Suppl 96:188-193, 2006.
181. Ostrowski RP, Tang J, and Zhang JH. Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. Stroke 37:1314-1318, 2006. (Pubitemid 43731882)
182. Paffenholz R, Bergstrom RA, Pasutto F, Wabnitz P, Munroe RJ, Jagla W, Heinzmann U, Marquardt A, Bareiss A, Laufs J, Russ A, Stumm G, Schimenti JC, and Bergstrom DE. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev 18:486-491, 2004. (Pubitemid 38372805)
183. Pao M, Wiggs EA, Anastacio MM, Hyun J, DeCarlo ES, Miller JT, Anderson VL, Malech HL, Gallin JI, and Holland SM. Cognitive function in patients with chronic granulomatous disease: a preliminary report. Psychosomatics 45: 230-234, 2004. (Pubitemid 38621532)
184. Park KW and Jin BK. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: role of neuronal NADPH oxidase. J Neurosci Res 86:1053-1063, 2008.
185. Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S, Carlson GA, and Iadecola C. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25:1769-1777, 2005. (Pubitemid 40279282)
186. Park L, Zhou P, Pitstick R, Capone C, Anrather J, Norris EH, Younkin L, Younkin S, Carlson G, McEwen BS, and Iadecola C. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci USA 105: 1347-1352, 2008.
187. Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, and Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278:13309-13317, 2003. (Pubitemid 36800102)
188. Pawate S, Shen Q, Fan F, and Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ. J Neurosci Res 77:540-551, 2004. (Pubitemid 39007006)
189. Peng J, Stevenson FF, Oo ML, and Andersen JK. Ironenhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. Free Radic Biol Med 46:312-320,2009. Epub 2008 Nov 7.
190. Pramatarova A, Laganiere J, Roussel J, Brisebois K, and Rouleau GA. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21:3369-3374, 2001. (Pubitemid 32422802)
191. Puntambekar P, Mukherjea D, Jajoo S, and Ramkumar V. Essential role of Rac1/NADPH oxidase in nerve growth factor induction of TRPV1 expression. J Neurochem 95: 1689-1703, 2005. (Pubitemid 41804065)
192. Pyne-Geithman GJ, Morgan CJ, Wagner K, Dulaney EM, Carrozzella J, Kanter DS, Zuccarello M, and Clark JF. Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 25:1070-1077, 2005. (Pubitemid 41061722)
193. Qian L, Gao X, Pei Z, Wu X, Block M, Wilson B, Hong JS, and Flood PM. NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation. Parkinsonism Relat Disord 13(suppl 3):S316-S320, 2007. (Pubitemid 351215261)
194. Qian L, Wei SJ, Zhang D, Hu X, Xu Z, Wilson B, El-Benna J, Hong JS, and Flood PM. Potent anti-inflammatory and neuroprotective effects of TGF-betal are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol 181: 660-668, 2008.
195. Qian L, Xu Z, Zhang W, Wilson B, Hong JS, and Flood PM. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflammation 4:23, 2007. (Pubitemid 350066535)
196. Qin B, Cartier L, Dubois-Dauphin M, Li B, Serrander L, and Krause KH. A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiol Aging 27: 1577-1587, 2006. (Pubitemid 44349157)
197. Qin L, Liu Y, Cooper C, Liu B, Wilson B, and Hong JS. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 83:973-983, 2002. (Pubitemid 35316048)
198. Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, and Hong JS. NADPH oxidase mediates lipopolysaccharideinduced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 279:1415-1421, 2004. (Pubitemid 38082669)
199. Rafii MS and Hillis AE. Compendium of cerebrovascular diseases. Int Rev Psychiatry 18:395-407, 2006.
200. Rammal H, Bouayed J, Younos C, and Soulimani R. Evidence that oxidative stress is linked to anxiety-related behaviour in mice. Brain Behav Immun 22:1156-1159, 2008.
201. Rammal H, Bouayed J, Younos C, and Soulimani R. The impact of high anxiety level on the oxidative status of mouse peripheral blood lymphocytes, granulocytes and monocytes. Eur J Pharmacol 589:173-175, 2008.
202. Reinehr R, Gorg B, Becker S, Qvartskhava N, Bidmon HJ, Selbach O, Haas HL, Schliess F, and Haussinger D. Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia 55:758-771, 2007. (Pubitemid 46663028)
203. Rodriguez-Pallares J, Parga JA, Munoz A, Rey P, Guerra MJ, and Labandeira-Garcia JL. Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamineinduced degeneration of dopaminergic neurons. J Neurochem 103:145-156, 2007. (Pubitemid 47404195)
204. Rodriguez-Pallares J, Rey P, Parga JA, Munoz A, Guerra MJ, and Labandeira-Garcia JL. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol Dis 31:58-73, 2008.
205. Roepstorff K, Rasmussen I, Sawada M, Cudre-Maroux C, Salmon P, Bokoch G, van Deurs B, and Vilhardt F. Stimulusdependent regulation of the phagocyte NADPH oxidase by a VAV1, Rac1, and PAK1 signaling axis. J Biol Chem 283: 7983-7993, 2008.
206. San Jose G, Fortuno A, Beloqui O, Diez J, and Zalba G. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci (Lona) 114:173-182, 2008. (Pubitemid 351293993)
207. Savitt JM, Dawson VL, and Dawson TM. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116:1744-1754, 2006. (Pubitemid 44033293)
208. Schappi MG, Jaquet V, Belli DC, and Krause KH. Hyperinflammation in chronic granulomatous disease and antiinflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol 30:255-271, 2008.
209. Schrenzel J, Serrander L, Banfi B, Nusse O, Fouyouzi R, Lew DP, Demaurex N, and Krause KH. Electron currents generated by the human phagocyte NADPH oxidase. Nature 392:734-737, 1998. (Pubitemid 28207797)
210. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, and Krause KH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406:105-114, 2007. (Pubitemid 47264740)
211. Serrano F, Kolluri NS, Wientjes FB, Card JP, and Klann E. NADPH oxidase immunoreactivity in the mouse brain. Brain Res 988:193-198, 2003. (Pubitemid 37289510)
212. Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, and Sun GY. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 106:45-55, 2008. (Pubitemid 351840199)
213. Shimo-Nakanishi Y, Hasebe T, Suzuki A, Mochizuki H, Nomiyama T, Tanaka Y, Nagaoka I, Mizuno Y, and Urabe T. Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 175:109-115, 2004. (Pubitemid 38746917)
214. Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, and Fujimoto S. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 273:5-9, 2000. (Pubitemid 30426853)
215. Shin HK, Lee JH, Kim KY, Kim CD, Lee WS, Rhim BY, and Hong KW. Impairment of autoregulatory vasodilation by NAD(P)H oxidase-dependent superoxide generation during acute stage of subarachnoid hemorrhage in rat pial artery. J Cereb Blood Flow Metab 22:869-877, 2002.
216. Shiu C, Barbier E, Di Cello F, Choi HJ, and Stins M. HIV-1 gp120 as well as alcohol affect blood-brain barrier permeability and stress fiber formation: involvement of reactive oxygen species. Alcohol Clin Exp Res 31:130-137, 2007. (Pubitemid 46025375)
217. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, and Marsden CD. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348-355, 1994. (Pubitemid 24280055)
218. Simpson EP, Yen AA, and Appel SH. Oxidative stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol 15:730-736, 2003. (Pubitemid 38156299)
219. Sirota P, Gavrieli R, and Wolach B. Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil Chemotaxis, superoxide production and bactericidal activity. Psychiatry Res 121:123-132, 2003. (Pubitemid 37500982)
220. Smith KJ, Kapoor R, and Felts PA. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9:69-92, 1999. (Pubitemid 29056521)
221. Stasia MJ and Li XJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol 30: 209-235, 2008.
222. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein HG, and Bogerts B. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatry Res 42:151-157, 2008. (Pubitemid 350061255)
223. Steinman L and Zamvil SS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60:12-21, 2006.
224. Streit WJ. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 77:1-8, 2004.
225. Suh SW, Gum ET, Hamby AM, Chan PH, and Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 117:910-918, 2007. (Pubitemid 46556747)
226. Sun C, Sellers KW, Sumners C, and Raizada MK. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ Res 96:659-666, 2005. (Pubitemid 40478333)
227. Sun HN, Kim SU, Lee MS, Kim SK, Kim JM, Yim M, Yu DY, and Lee DS. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent activation of phosphoinositide 3-kinase and p38 mitogen-activated protein kinase signal pathways is required for lipopolysaccharideinduced microglial phagocytosis. Biol Pharm Bull 31:1711-1715, 2008.
228. Suzukawa K, Miura K, Mitsushita J, Resau J, Hirose K, Crystal R, and Kamata T. Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species. J Biol Chem 275:13175-13178, 2000. (Pubitemid 30257368)
229. Syburra C and Passi S. Oxidative stress in patients with multiple sclerosis. Ukr Biokhim Zh 71:112-115, 1999. (Pubitemid 129641346)
230. Takeya R, Taura M, Yamasaki T, Naito S, and Sumimoto H. Expression and function of Noxo1gamma, an alternative splicing form of the NADPH oxidase organizer 1. FEBS J 273:3663-3677, 2006. (Pubitemid 44166648)
231. Tammariello SP, Quinn MT, and Estus S. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J Neurosci 20: RC53, 2000.
232. Tang J, Liu J, Zhou C, Ostanin D, Grisham MB, Neil Granger D, and Zhang JH. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage. J Neurochem 94: 1342-1350, 2005. (Pubitemid 41232589)
233. Tang LL, Ye K, Yang XF, and Zheng JS. Apocynin attenuates cerebral infarction after transient focal ischaemia in rats. J Int Med Res 35:517-522, 2007. (Pubitemid 47261114)
234. Tang XN, Cairns B, Cairns N, and Yenari MA. Apocynin improves outcome in experimental stroke with a narrow dose range. Neuroscience 154:556-562, 2008.
235. Tejada-Simon MV, Serrano F, Villasana LE, Kanterewicz BI, Wu GY, Quinn MT, and Klann E. Synaptic localization of a functional NADPH oxidase in the mouse hippocampus. Mol Cell Neurosci 29:97-106, 2005. (Pubitemid 40603884)
236. Titova E, Ostrowski RP, Sowers LC, Zhang JH, and Tang J. Effects of apocynin and ethanol on intracerebral haemorrhage-induced brain injury in rats. Clin Exp Pharmacol Physiol 34:845-850, 2007. (Pubitemid 47083966)
237. Tsaluchidu S, Cocchi M, Tonello L, and Puri BK. Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 8(suppl 1): S5, 2008. (Pubitemid 351964890)
238. Tsatmali M, Walcott EC, and Crossin KL. Newborn neurons acquire high levels of reactive oxygen species and increased mitochondrial proteins upon differentiation from progenitors. Brain Res 1040:137-150, 2005. (Pubitemid 40459629)
239. Tsatmali M, Walcott EC, Makarenkova H, and Crossin KL. Reactive oxygen species modulate the differentiation of neurons in clonal cortical cultures. Mol Cell Neurosci 33: 345-357, 2006. (Pubitemid 44820854)
240. Tsukamoto E, Hashimoto Y, Kanekura K, Niikura T, Aiso S, and Nishimoto I. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells. J Neurosci Res 73:627-636, 2003. (Pubitemid 37071748)
241. Turchan-Cholewo J, Dimayuga VM, Gupta S, Gorospe RM, Keller JN, and Bruce-Keller AJ. NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat. Antioxid Redox Signal 11: 193-204, 2009.
242. Vallet P, Charnay Y, Steger K, Ogier-Denis E, Kovari E, Herrmann F, Michel JP, and Szanto I. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132:233-238, 2005. (Pubitemid 40417898)
243. van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, and Kahn RS. Microglia activation in recent-onset schizophrenia: a quantitative (R)[11C]PK11195 positron emission tomography study. Biol Psychiatry 64:820-822, 2008.
244. van der Goes A, Brouwer J, Hoekstra K, Roos D, van den Berg TK, and Dijkstra CD. Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol 92:67-75, 1998. (Pubitemid 29015991)
245. van der Veen RC, Dietlin TA, Hofman FM, Pen L, Segal BH, and Holland SM. Superoxide prevents nitric oxidemediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice. J Immunol 164:5177-5183, 2000. (Pubitemid 30305193)
246. Vilhardt F. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 37:17-21, 2005.
247. Vladimirova O, Lu FM, Shawver L, and Kaiman B. The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls. Inflamm Res 48: 412-416, 1999. (Pubitemid 29361251)
248. Vladimirova O, O'Connor J, Cahill A, Alder H, Butunoi C, and Kaiman B. Oxidative damage to DNA in plaques of MS brains. Mult Scler 4:413-1118, 1998. (Pubitemid 28515351)
249. von Bohlen Und Halbach O. Modeling neurodegenerative diseases in vivo review. Neurodegener Dis 2:313-3120, 2005.
250. Wakisaka Y, Miller JD, Chu Y, Baumbach GL, Wilson S, Faraci FM, Sigmund CD, and Heistad DD. Oxidative stress through activation of NAD(P)H oxidase in hypertensive mice with spontaneous intracranial hemorrhage. J Cereb Blood Flow Metab 28:1175-1185, 2008. (Pubitemid 351733357)
251. Walder CE, Green SP, Darbonne WC, Mathias J, Rae J, Dinauer MC, Curnutte JT, and Thomas GR. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 28:2252-2258, 1997. (Pubitemid 27497931)
252. Wang G, Anrather J, Glass MJ, Tarsitano MJ, Zhou P, Frys KA, Pickel VM, and Iadecola C. Nox2, Ca2+, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48: 482-489, 2006. (Pubitemid 44253744)
253. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, and Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 24: 5516-5524, 2004. (Pubitemid 38812634)
254. Wang G, Milner TA, Speth RC, Gore AC, Wu D, Iadecola C, and Pierce JP. Sex differences in angiotensin signaling in bulbospinal neurons in the rat rostral ventrolateral medulla. Am }Physiol Regul Integr Comp Physiol 295:R1149-R1157, 2008.
255. Wang N, Xie K, Huo S, Zhao J, Zhang S, and Miao J. Suppressing phosphatidylcholine-specific phospholipase C and elevating ROS level, NADPH oxidase activity and Rb level induced neuronal differentiation in mesenchymal stem cells. J Cell Biochem 100:1548-1557, 2007. (Pubitemid 46515586)
256. Wang Q, Rowan MJ, and Anwyl R. Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J Neurosci 24:6049-6056, 2004. (Pubitemid 38891095)
257. Wang Q, Sun AY, Simonyi A, Kalogeris TJ, Miller DK, Sun GY, and Korthuis RJ. Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic Biol Med 43: 1048-1060, 2007. (Pubitemid 47302653)
258. Wang Q, Tompkins KD, Simonyi A, Korthuis RJ, Sun AY, and Sun GY. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 1090:182-189, 2006. (Pubitemid 43817927)
259. Wang XP and Ding HL. Alzheimer's disease: epidemiology, genetics, and beyond. Neurosci Bull 24:105-109, 2008.
260. Wilkinson B, Koenigsknecht-Talboo J, Grommes C, Lee CY, and Landreth G. Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. J Biol Chem 281:20842-20850, 2006. (Pubitemid 44115425)
261. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, and Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771, 2002. (Pubitemid 35386294)
262. Wu DC, Re DB, Nagai M, Ischiropoulos H, and Przedborski S. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci USA 103:12132-12137, 2006. (Pubitemid 44215823)
263. Xia CF, Yin H, Borlongan CV, Chao J, and Chao L. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Hum Gene Ther 15:1243-1254, 2004. (Pubitemid 40052436)
264. Xia CF, Yin H, Borlongan CV, Chao J, and Chao L. Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis. Exp Neurol 197:521-530, 2006. (Pubitemid 43077160)
265. Yamamoto E, Tamamaki N, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, Fukuda M, Matsuba S, Ogawa H, and Kim-Mitsuyama S. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 39:3049-3056, 2008.
266. Yang CS, Lee HM, Lee JY, Kim JA, Lee SJ, Shin DM, Lee YH, Lee DS, El-Benna J, and Jo EK. Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia. J Neuroinflammation 4:27, 2007. (Pubitemid 351248155)
267. Yang S, Yang J, Yang Z, Chen P, Fraser A, Zhang W, Pang H, Gao X, Wilson B, Hong JS, and Block ML. Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress. J Pharmacol Exp Ther 319:595-603, 2006. (Pubitemid 44776362)
268. Ye S, Zhong H, Yanamadala S, and Campese VM. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 48:309-315, 2006. (Pubitemid 44309828)
269. Zekry D, Epperson TK, and Krause KH. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? IUBMB Life 55:307-313, 2003. (Pubitemid 36975540)
270. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, and Veasey SC. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care. Med 172:921-929, 2005. (Pubitemid 41369078)
271. Zhang D, Hu X, Wei SJ, Liu J, Gao H, Qian L, Wilson B, Liu G, and Hong JS. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. J Neuroinflammation 5:21, 2008. (Pubitemid 351803826)
272. Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhou Y, Hong JS, and Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 19: 533-542, 2005. (Pubitemid 40471244)
273. Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Hong JS, and Liu B. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J 18:589-591, 2004.
274. Zhang Y, Dawson VL, and Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis 7:240-250, 2000.
275. Zheng JS, Zhan RY, Zheng SS, Zhou YQ, Tong Y, and Wan S. Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats. Stroke 36:1059-1064, 2005.
276. Zhou J, Zhang S, Zhao X, and Wei T. Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-betal-42. J Pineal Res 45:157-165, 2008.
277. Zhu D, Lai Y, Shelat PB, Hu C, Sun GY, and Lee JC. Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction. J Neurosci 26:11111-11119, 2006. (Pubitemid 44772199)
278. Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, and Veasey SC. Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model. J Neurosci 27:10060-10071, 2007. (Pubitemid 47404016)
279. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, and Davisson RL. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95:532-539, 2004. (Pubitemid 39180933)
280. Zimmerman MC, Sharma RV, and Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45:717-723, 2005.